Steady Growth Supports J&J’s Wide Moat By: Morningstar Article January 26, 2016 at 11:38 AM EST Headwinds from the firm’s drug business shouldn't derail strong returns over the long run, says Morningstar’s Damien Conover. Read More >> Related Stocks: Johnson & Johnson